Inventor
TOBIAS RAUM
Inventor
DE
Overview
Patents· 25 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
C07Kprimary
C07KPeptides33%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations32%
A61KPreparations for medical, dental or toiletry purposes29%
C12NMicroorganisms or enzymes7%
PatentTitleYear
12,441,796Antibody constructs for CDH19 and CD3202512,435,139Antibody constructs for DLL3 and CD3202512,428,491PSMA and CD3 bispecific T cell engaging antibody constructs202512,312,412MAGEB2 binding constructs202512,304,952Antibody constructs for DLL3 and CD3202512,297,292Antibody constructs for CDH19 and CD3202512,281,172Cross-species-specific PSMAxCD3 bispecific single chain antibody202512,281,176Binding molecules for BCMA and CD3202512,281,175Binding molecules for BCMA and CD3202512,258,404Bispecific antibody construct directed to MUC17 and CD3202512,258,411Anti-CCR8 antibodies and uses thereof202512,152,078Nucleic acids encoding anitbody constructs binding EGFR VIII and CD3202411,987,633Cross-species-specific single domain bispecific single chain antibody202411,926,666Bispecific antibody constructs for CDH3 and CD3202411,925,684Compositions comprising cross-species-specific antibodies and uses thereof202411,884,720Antibody constructs for MSLN and CD3202411,692,031Antibody constructs for CLDN18.2 and CD3202311,661,462Optimized cross-species specific bispecific single chain antibody contructs202311,591,396Antibody constructs for DLL3 and CD3202311,498,964Antibody constructs for CDH19 and CD3202211,472,886Cross-species-specific PSMAxCD3 bispecific single chain antibody202211,447,567Antibody constructs for FLT3 and CD3202211,434,302Bispecific T cell engaging antibody constructs202211,352,433BCMA and CD3 bispecific T cell engaging antibody constructs202211,155,629Method for treating glioblastoma or glioma with antibody constructs for EGFRVIII and CD32021Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2021–2025Patents assigned to AMGEN RES MUNICH GMBH (25)· patent assignee history
2021–2025Based in DE· patent location history
2022–2025Patents assigned to AMGEN INC (11)· patent assignee history
2025Patents assigned to IMMATICS BIOTECHNOLOGIES GMBH (1)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| AMGEN RES MUNICH GMBH | 25 | 2021–2025 |
| AMGEN INC | 11 | 2022–2025 |
| IMMATICS BIOTECHNOLOGIES GMBH | 1 | 2025 |
Locations
| Location | Patents | Span |
|---|---|---|
| DE | 25 | 2021–2025 |